Cambridge Nutritional Sciences plc (LON:CNSL – Get Free Report) insider Jeremy Millard purchased 168,776 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were bought at an average cost of GBX 2 per share, with a total value of £3,375.52.
Cambridge Nutritional Sciences Stock Up 11.1%
Shares of CNSL opened at GBX 2.50 on Wednesday. Cambridge Nutritional Sciences plc has a fifty-two week low of GBX 1.86 and a fifty-two week high of GBX 4.38. The company’s fifty day moving average is GBX 2.73 and its two-hundred day moving average is GBX 3.08. The firm has a market cap of £5.95 million, a PE ratio of 3.57 and a beta of 3.89.
Cambridge Nutritional Sciences (LON:CNSL – Get Free Report) last released its quarterly earnings data on Monday, November 10th. The company reported GBX (0.20) EPS for the quarter. Cambridge Nutritional Sciences had a negative return on equity of 3.34% and a negative net margin of 3.36%. As a group, equities research analysts anticipate that Cambridge Nutritional Sciences plc will post 0.036865 earnings per share for the current year.
About Cambridge Nutritional Sciences
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Further Reading
- Five stocks we like better than Cambridge Nutritional Sciences
- What is a Dividend King?
- Buyer Beware: Carvana Is Driving an Auto Lending Crisis
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- What Investors Need to Know About Upcoming IPOs
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
